Ackrell Capital Cannabis Investment Report (Dec 2017) – Company Valuations and Multiples
Ackrell Capital Cannabis Investment Report (Dec 2017) – Company Valuations and Multiples The document is a routine financial valuation report for publicly traded cannabis companies. It contains no references to political figures, government agencies, foreign leaders, or alleged misconduct. Consequently, it offers no actionable investigative leads. Key insights: Provides EV, revenue, EBITDA, and valuation multiples for major TSX‑listed cannabis firms (e.g., Aphria, Aurora, Canopy Growth).; Includes similar data for TSX Venture Exchange cannabis‑related companies.; Source cited as S&P Global Market Intelligence; data is standard market intelligence.
Summary
Ackrell Capital Cannabis Investment Report (Dec 2017) – Company Valuations and Multiples The document is a routine financial valuation report for publicly traded cannabis companies. It contains no references to political figures, government agencies, foreign leaders, or alleged misconduct. Consequently, it offers no actionable investigative leads. Key insights: Provides EV, revenue, EBITDA, and valuation multiples for major TSX‑listed cannabis firms (e.g., Aphria, Aurora, Canopy Growth).; Includes similar data for TSX Venture Exchange cannabis‑related companies.; Source cited as S&P Global Market Intelligence; data is standard market intelligence.
Tags
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.